Pioglitazone Improves Whole-Body Aerobic Capacity in MetS

Share this content:
Pioglitazone Improves Whole-Body Aerobic Capacity in MetS
Pioglitazone Improves Whole-Body Aerobic Capacity in MetS

FRIDAY, Dec. 16, 2016 (HealthDay News) -- For adults with metabolic syndrome (MetS), pioglitazone treatment improves whole-body aerobic capacity, according to a study published online Dec. 12 in the Journal of Diabetes Investigation.

Takashi Yokota, M.D., Ph.D., from the Hokkaido University Graduate School of Medicine in Sapporo, Japan, and colleagues examined the effects of pioglitazone treatment on whole-body aerobic capacity and skeletal muscle energy metabolism in 14 male patients with MetS. Patients received oral 15 mg/day pioglitazone for four months. Exercise testing with a bicycle ergometer was performed before and after pioglitazone treatment to assess whole-body aerobic capacity.

The researchers found that although daily physical activity was comparable before and after treatment, pioglitazone significantly increased peak oxygen uptake and anaerobic threshold (AT) (both P < 0.05). After pioglitazone treatment there was a 26 percent reduction in intramyocellular lipid (IMCL) content, indicating an improvement in skeletal muscle fatty acid metabolism. There was also a 13 percent decrease in muscle phosphocreatine loss during exercise, indicating an improvement in skeletal muscle high-energy phosphate metabolism. There was a close correlation for the increase in AT with the decrease in IMCL content after treatment with pioglitazone.

"Pioglitazone significantly improved the MetS patients' whole-body aerobic capacity and skeletal muscle energy metabolism," the authors write. "The beneficial effect of pioglitazone on whole-body aerobic capacity might be at least in part via improved fatty acid metabolism in the skeletal muscle."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »